In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

Focus on - 24 June



describing the effect of evolving ESC Guidelines on the prevalence of indication for CRT

During the last decade, clinical studies and subsequently European Society of Cardiology (ESC) Guidelines have broadened the indication for Cardiac Resynchronization Therapy (CRT) in Heart Failure (HF). We aimed at describing the effect of evolving ESC Guidelines on the prevalence of indication for CRT in patients with HF and used the Swedish Heart Failure Registry to select 17 193 patients.

The prevalence of having CRT indication increased significantly and substantially from 25 % (applying ESC 2007 guidelines) to 36 % (applying ESC 2013 guidelines). This prevalence was orders of magnitude higher than actual CRT implantation (7%), revealing a substantial underutilization of CRT in HF.

I have been a regular attendee of EHRA EUROPACE - CARDIOSTIM for several years and shall continue to be To my mind, it is an excellent platform for acquiring scientific and clinical state-of-the-art input, as well as for networking with colleagues from all over Europe.

Doctor Marcus Stahlberg, Sweden.

Presenter of the abstract entitled "Prevalence of indication for cardiac resynchronization therapy: effect of evolving clinical guidelines" that will be on display for the duration of the congress in the Poster Area.

Doctor Marcus Stahlberg, Sweden.
Presenter of the abstract entitled "Prevalence of indication for cardiac resynchronization therapy: effect of evolving clinical guidelines" that will be on display for the duration of the congress in the Poster Area.
Authors: Marcus Ståhlberg, MD, PhD, FESC - Department of Cardiology / Karolinska University Hospital - Stockholm, Sweden.

a great opportunity to interact with colleagues

It is an honor for me to present at EHRA EUROPACE - CARDIOSTIM congress my work on the clinical significance of left bundle branch block, in patients undergoing pacemaker implantation. We measured the prevalence and we analysed the prognostic significance of LBBB according to classical or published stricter criteria.

This important scientific session will be a great opportunity to interact with colleagues and exchange experiences for my future research activity.

Dr. Mazza, Abstract n. 40792: Prevalence and clinical significance of LBBB according to classical or strict definition criteria in permanent pacemaker patients

EHRA inventors award was a challenge for me that I could not miss!

One day I was introduced to famous French doctor, Guy Fontaine who raised his interest in my knowledge of physics and medicine during the congress meeting at St Stefan in 1998. Since he was an opinion leader in ARVD he inspired me to look for this rare condition in Serbia. Our communication continued through e-mailand a couple of gatherings in Belgrade and scientific meetings abroad. After my first presentation during EUROECHO meeting in Barcelona 2003, when I reported of V sign as pathognomonic for ARVD on echo, he led the path to publication as Invited Editor for Cardinale Journal in 2004. V sign (visual) was primarily described in 2D black and white technique, as „notch“ on PW tissue Doppler signal. Since it was meticulous work to look for, it has been often neglected by others. When tissue color doppler technique appeared it was easier to delienate and spot V sign. Diagnostics were held back by expensive equipment and a lack of personel interested in ARVC/D, and disease rarity. Afterwards, I was asked to write a chapter summarizing my results in in a book titled "Progress in cardiac arrhythmia research“ Ed. Ira R. Tarkowicz published by Nova Science.

10 years earlier I had started a database of ARVC/D in Serbia and included all patients with overt phase of the disease. As the time passed by I had noted a similar pattern of behaviour of the interventricular septum that guided my research in explanation of V sign as the earliest sign to emerge in ARVC/D. That is how I have gathered the group of ARVD patients with almost everything normal on echo except for V sign. The group fulfilled WHO criteria for diagnosis of ARVC/D concerning existing relevant score system of major and minor criteria. In the follow up of 8±5 years I was able to look for subtle changes on VCG. V sign was represented on vector as T sign ( Tau or "true“).

IPA I Mini grants programme came to Serbia for the first time in 2011 and brought with it the possibility to apply for funds. I decided to try to get a grant for making software that could solve an insurmountable problem in diagnosing ARVC/D in its silent phase. My application was successful, so project Luminis got almost 94.000 Euros for the period of 12 months which resulted in PCT patented software named VCG Sophie.

The opportunity of EHRA inventors award was a challenge that I could not miss! I remember Dr Fontaine once said „One day, a young lady from Serbia enters the highest level of International science! “ And I replied back "before making a discovery, you have to be discovered first!“ Thanks to many other people who provided such opportunity it was possible.

For me that dream has come true…

Associate Professor Vranic Ivana, Serbia.
Presenter in the EHRA Inventors Award session "A method and system for vector analysis of lectrocardiogram in assessment of risk of sudden cardiac death (SCD) due to arrhythmogenic right ventricular dysplasia/cardiomyopathy by quantifying micro scars (i.e. “bites”) in three dimensional vector loops."

 

Online post-congress resources

Please note that  all the EHRA EUROPACE-CARDIOSTIM 2015 online scientific resources  will be available online with a restricted access to 2015 EHRA Members.

 

Pictures

Find your face in the crowd on our Facebook gallery